Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD8-PET”

16 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 16 results

Not applicableNot Yet RecruitingNCT07819474
What this trial is testing

Optimizing Tumor-Infiltrating Lymphocyte (TIL) Harvest Site and Patient Selection With CD8-PET Imaging in Patients With

Who this might be right for
Tumor Infiltrating LymphocyteCD8-PETAdvanced Melanoma
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT03802123
What this trial is testing

⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for PET/CT in Patients With Metastatic Solid Tumors

Who this might be right for
Positron-Emission TomographyMetastatic Solid Tumors
ImaginAb, Inc. 52
Very early researchActive Not RecruitingNCT05279027
What this trial is testing

Zr89 + PET Companion Trial

Who this might be right for
Melanoma (Skin)
Abramson Cancer Center at Penn Medicine 6
Very early researchNot Yet RecruitingNCT07700121
What this trial is testing

PICSTAT Pilot Study for CD8 PET/CT-Guided Lifileucel Treatment in Advanced Melanoma

Who this might be right for
Unresectable or Metastatic Melanoma
Abramson Cancer Center at Penn Medicine 10
Testing effectiveness (Phase 2)Ended earlyNCT05744128
What this trial is testing

CD8 Minibody Repeatability Study

Who this might be right for
MelanomaRenal Cell Carcinoma
ImaginAb, Inc. 3
Early research (Phase 1)Study completedNCT03107663
What this trial is testing

⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's Lymphoma

Who this might be right for
Positron-Emission TomographyImmunomodulationMetastatic Solid Malignancies+1 more
ImaginAb, Inc. 15
Early research (Phase 1)Looking for participantsNCT06650163
What this trial is testing

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

Who this might be right for
GliomaMalignant Brain NeoplasmMeningioma+1 more
Jonsson Comprehensive Cancer Center 20
Early research (Phase 1)Study completedNCT06863233
What this trial is testing

CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerNon Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center 4
Not applicableEnded earlyNCT04874818
What this trial is testing

CD8+ T-cell PET/CT Imaging in COVID-19 Patients

Who this might be right for
Lymphopenia Due to COVID-19T-cellPET Imaging
Radboud University Medical Center 5
Early research (Phase 1)WithdrawnNCT04955262
What this trial is testing

A CD8 Positron Emission Tomography With Computed Tomography (PET/CT) Study Using ⁸⁹Zr Df-IAB22M2C in Patients With Metastatic Melanoma Receiving Bempegaldesleukin (NKTR-214) and Nivolumab

Who this might be right for
Metastatic Melanoma
Nektar Therapeutics
Very early researchStudy completedNCT05126927
What this trial is testing

A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors

Who this might be right for
Solid Tumor
SmartNuclide Biopharma 11
Early research (Phase 1)Looking for participantsNCT05849467
What this trial is testing

Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy

Who this might be right for
Progressive Multifocal LeukoencephalopathyMultiple SclerosisOther Neuroinflammatory Diseases With BBB Leakage
National Institute of Neurological Disorders and Stroke (NINDS) 15
Early research (Phase 1)Looking for participantsNCT05371132
What this trial is testing

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

Who this might be right for
Metastatic Malignant Solid NeoplasmLymphoma
City of Hope Medical Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT06534190
What this trial is testing

CD8 PET Imaging in Metastatic Solid Tumours

Who this might be right for
Locally Advanced Solid Tumor
University Medical Center Groningen 30
Testing effectiveness (Phase 2)Ended earlyNCT05397171
What this trial is testing

A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours

Who this might be right for
Urinary Bladder NeoplasmsColorectal CancerCarcinoma, Non-Small-Cell Lung
AstraZeneca 17
Early research (Phase 1)Looking for participantsNCT05259709
What this trial is testing

ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With Cemiplimab

Who this might be right for
Advanced Solid TumorMetastatic Solid Tumor
Regeneron Pharmaceuticals 50